Acquired slow-channel syndrome

被引：0

作者：

Scola, RH ^{[1
]}

Werneck, LC ^{[1
]}

Iwamoto, FM ^{[1
]}

Comerlato, EA ^{[1
]}

Kay, CK ^{[1
]}

机构：

[1] Univ Fed Parana, Hosp Clin, Neuromuscular Disorders Div, BR-80069900 Curitiba, Parana, Brazil

来源：

MUSCLE & NERVE | 2000年 / 23卷 / 10期

关键词：

electromyography; myasthenia gravis; neuromuscular junction; slow-channel syndrome;

D O I：

10.1002/1097-4598(200010)23:10<1582::AID-MUS16>3.3.CO;2-8

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We report the case of a 37-year-old man with clinical and electrophysiological features of hereditary slow-channel syndrome (SCS) and antibodies against acetylcholine receptors (AChR-Abs). He presented with weakness of shoulder and hand muscles. A supramaximal single stimulus to the motor nerves disclosed a double compound muscle action potential (CMAP). Repetitive stimulation of ulnar, suprascapular, and median nerves showed a CMAP decrement greater than 10%. The patient responded to pyridostigmine. This report confirms the importance of AChR-Ab titers in suspected cases of hereditary SCS because patients with positive AChR-Abs may have a better response to available treatments. (C) 2000 John Wiley & Sons, Inc.

引用

页码：1582 / 1585

页数：4

共 50 条

[31] Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome
Groshong, Jason S.
Spencer, Melissa J.
Bhattacharyya, Bula J.
Kudryashova, Elena
Vohra, Bhupinder P. S.
Zayas, Roberto
Wollmann, Robert L.
Miller, Richard J.
Gomez, Christopher M.
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (10): : 2903 - 2912
[32] THERAPEUTIC IMPLICATIONS OF SLOW-CHANNEL BLOCKADE IN CARDIOCIRCULATORY DISORDERS
ELLRODT, G
CHEW, CYC
SINGH, BN
CIRCULATION, 1980, 62 (04) : 669 - 679
[33] A LEUCINE-TO-PHENYLALANINE SUBSTITUTION IN THE ACETYLCHOLINE-RECEPTOR ION-CHANNEL IN A FAMILY WITH THE SLOW-CHANNEL SYNDROME
GOMEZ, CM
GAMMACK, JT
NEUROLOGY, 1995, 45 (05) : 982 - 985
[34] Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model
Vohra, Bhupinder P. S.
Groshong, Jason S.
Zayas, Roberto
Wollmann, Robert L.
Gomez, Christopher M.
NEUROBIOLOGY OF DISEASE, 2006, 23 (02) : 462 - 470
[35] Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms
Gomez, CM
Maselli, RA
Vohra, BPS
Navedo, N
Stiles, JR
Charnet, P
Schott, K
Rojas, L
Keesey, J
Verity, A
Wollmann, RW
Lasalde-Dominicci, J
ANNALS OF NEUROLOGY, 2002, 51 (01) : 102 - 112
[36] Novel ε subunit mutation of the muscle acetylcholine receptor causing a slow-channel congenital myasthenic syndrome
Outteryck, O.
Richard, P.
Lacour, A.
Fournier, E.
Zephir, H.
Gaudon, K.
Eymard, B.
Hantai, D.
Vermersch, P.
Stojkovic, T.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (04): : 450 - 451
[37] Efficacy of salbutamol monotherapy in slow-channel congenital myasthenic syndrome caused by a novel mutation in CHRND
Tawara, Nozomu
Yamashita, Satoshi
Takamatsu, Koutaro
Yamasaki, Yoshimune
Mukaino, Akihiro
Nakane, Shunya
Farshadyeganeh, Paniz
Ohno, Kinji
Ando, Yukio
MUSCLE & NERVE, 2021, 63 (04) : E30 - E32
[38] Allele-specific RNA interference to target a model of slow-channel congenital myasthenic syndrome
McClorey, G.
Beeson, D.
Wood, M.
NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 749 - 749
[39] Mutations in the muscle acetylcholine receptor alpha subunit gene in slow-channel congenital myasthenic syndrome
Beeson, D
Newland, C
Croxen, R
Vincent, A
NewsomDavis, J
ANNALS OF NEUROLOGY, 1996, 40 (03) : 487 - 488
[40] Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome
Zhu, Haipeng
Pytel, Peter
Gomez, Christopher M.
HUMAN MOLECULAR GENETICS, 2014, 23 (01) : 69 - 77

← 1 2 3 4 5 →